Updated:
Revvity
Revvity provides Life Sciences and Diagnostics products and services for disease research, drug development, screening and diagnosis.
Overview
Revvity supplies health science technologies, products and services for research, drug development and diagnostics. Its Life Sciences business supports cell, gene and protein research, helping pharmaceutical, biotechnology and research organizations study diseases and develop treatments. The company also has a Diagnostics segment. Across its businesses, it offers screening, detection, imaging, biomarker and informatics capabilities. For fiscal 2025, ended December 28, 2025, it reported revenue of approximately $2.856 billion and total assets of approximately $12.168 billion at year-end.
Company overview
- Legal name
- REVVITY, INC.
- Classification
- Public company
- Incorporated in
- Massachusetts
- SEC CIK
- 0000031791
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $2.9B | $241.2M | $12.2B | $919.9M | $582.9M | |
| FY2024USD | $2.8B | $270.4M | $12.4B | $1.2B | $628.3M | |
| FY2023USD | $2.8B | $693.1M | $13.6B | $913.2M | $91.3M | |
| FY2022USD | $3.3B | $569.2M | $14.1B | $454.4M | $679.8M |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Revvity in Altss
Track this company’s investors, transactions and relationships in Altss.